PANews reported on July 28 that according to Businessinsider, preclinical biopharmaceutical company Liminatus Pharma, Inc. (NASDAQ: LIMN) announced today that it plans to strategically expand into the cryptocurrency and blockchain fields. The company plans to establish a subsidiary called "American BNB Strategy" to lead its digital asset investment and management plan. Through this platform, Liminatus plans to raise and deploy up to US$500 million in phases, with the goal of making strategic long-term investments in BNB.